![]() |
Volumn 49, Issue 12, 2008, Pages 1516-1523
|
Gender differences in psychopharmacology;Geschlechterunterschiede in der neuropsychiatrischen pharmakotherapie
|
Author keywords
Gender specific differences; Pregnancy; Psychiatric disorders; Psychopharmacological agents; Side effects
|
Indexed keywords
AMFEBUTAMONE;
AMITRIPTYLINE;
ANTICONVULSIVE AGENT;
ANTIDEPRESSANT AGENT;
ARIPIPRAZOLE;
CITALOPRAM;
CLOMIPRAMINE;
CLOZAPINE;
DOPAMINE;
DOXEPIN;
DULOXETINE;
ELONTRIL;
ESCITALOPRAM;
ESTROGEN;
FLUOXETINE;
HALOPERIDOL;
HYPERICUM PERFORATUM EXTRACT;
IMIPRAMINE;
JANTREVE;
NEUROLEPTIC AGENT;
OLANZAPINE;
PALIPERIDONE;
PAROXAT;
PAROXETINE;
QUETIAPINE;
RISPERIDONE;
SEROTONIN;
SEROTONIN NORADRENALIN REUPTAKE INHIBITOR;
SEROTONIN UPTAKE INHIBITOR;
SERTRALINE;
TRICYCLIC ANTIDEPRESSANT AGENT;
TRIMIPRAMINE;
UNCLASSIFIED DRUG;
UNINDEXED DRUG;
VENLAFAXINE;
ZIPRASIDONE;
DEPRESSION;
DRUG EFFECT;
DRUG EFFICACY;
DRUG RESPONSE;
FEMALE;
HEART ARRHYTHMIA;
HIGH RISK POPULATION;
HUMAN;
HYPERGLYCEMIA;
MALE;
MENOPAUSE;
MENTAL DISEASE;
PREGNANCY;
PSYCHOPHARMACOLOGY;
REVIEW;
SEX DIFFERENCE;
SEXUAL DYSFUNCTION;
WEIGHT GAIN;
ABNORMALITIES, DRUG-INDUCED;
FEMALE;
HUMANS;
INFANT, NEWBORN;
MENTAL DISORDERS;
PREGNANCY;
PSYCHOTROPIC DRUGS;
SEX FACTORS;
TREATMENT OUTCOME;
|
EID: 57449107272
PISSN: 00209554
EISSN: None
Source Type: Journal
DOI: 10.1007/s00108-008-2233-6 Document Type: Review |
Times cited : (5)
|
References (35)
|